• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

生物膜自涂层仿生口服传递肠道微生物群。

Bioinspired oral delivery of gut microbiota by self-coating with biofilms.

机构信息

Shanghai Key Laboratory for Nucleic Acid Chemistry and Nanomedicine, Institute of Molecular Medicine, State Key Laboratory of Oncogenes and Related Genes, Shanghai Cancer Institute, Renji Hospital, School of Medicine, Shanghai Jiao Tong University, Shanghai 200127, China.

出版信息

Sci Adv. 2020 Jun 24;6(26):eabb1952. doi: 10.1126/sciadv.abb1952. eCollection 2020 Jun.

DOI:10.1126/sciadv.abb1952
PMID:32637620
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7314526/
Abstract

Transplanting beneficial bacteria to the gut microbiome can positively modulate the bacterial composition and remains of great interest in prevention and treatment. However, environmental assaults and rapid transit times in the gastrointestinal (GI) tract result in low oral bioavailability and limited intestinal colonization. Here, we describe a bioinspired strategy of self-coating with biofilms that endows the transplanted gut microbiota with superior resistance and adhesion capacity. Using clinical as a model probiotic bacterium, biofilm-coated probiotics demonstrate substantially improved GI tract tolerance and mucoadhesion in mice and swine. In particular, coated probiotics exhibit a 125-fold higher oral bioavailability and a 17 times greater intestinal colonization than uncoated bacteria in the porcine model. With notable ability to survive and reside in the GI tract, coated bacteria further show a significantly enhanced decolonization effect in mice colonized with . Self-coating with biofilms suggests a robust platform for oral doses of gut microbiota.

摘要

将有益细菌移植到肠道微生物群中可以积极调节细菌组成,在预防和治疗方面仍然具有很大的兴趣。然而,胃肠道(GI)中的环境攻击和快速传输时间导致口服生物利用度低和有限的肠道定植。在这里,我们描述了一种自我包被生物膜的仿生策略,赋予移植的肠道微生物群更好的抗性和粘附能力。使用临床作为模型益生菌细菌,生物膜包被的益生菌在小鼠和猪中表现出显著提高的胃肠道耐受性和粘膜粘附性。特别是,包被的益生菌在猪模型中表现出比未包被细菌高 125 倍的口服生物利用度和 17 倍的肠道定植率。由于具有在胃肠道中存活和驻留的显著能力,包被细菌在定植有 的小鼠中进一步显示出显著增强的去定植效果。生物膜的自我包被为口服剂量的肠道微生物群提供了一个强大的平台。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/143b/7314526/6bef738628cb/abb1952-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/143b/7314526/3ef1077ee275/abb1952-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/143b/7314526/4f061e1ccd75/abb1952-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/143b/7314526/a1124695fff4/abb1952-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/143b/7314526/f01ce0dae93d/abb1952-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/143b/7314526/5909322213e1/abb1952-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/143b/7314526/6bef738628cb/abb1952-F6.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/143b/7314526/3ef1077ee275/abb1952-F1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/143b/7314526/4f061e1ccd75/abb1952-F2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/143b/7314526/a1124695fff4/abb1952-F3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/143b/7314526/f01ce0dae93d/abb1952-F4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/143b/7314526/5909322213e1/abb1952-F5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/143b/7314526/6bef738628cb/abb1952-F6.jpg

相似文献

1
Bioinspired oral delivery of gut microbiota by self-coating with biofilms.生物膜自涂层仿生口服传递肠道微生物群。
Sci Adv. 2020 Jun 24;6(26):eabb1952. doi: 10.1126/sciadv.abb1952. eCollection 2020 Jun.
2
Biofilm-based delivery approaches and specific enrichment strategies of probiotics in the human gut.基于生物膜的益生菌传递方法和在人体肠道中的特异性富集策略。
Gut Microbes. 2022 Jan-Dec;14(1):2126274. doi: 10.1080/19490976.2022.2126274.
3
Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment.生物界面自组装生成脂质膜包裹的细菌,用于增强口服递送和治疗效果。
Nat Commun. 2019 Dec 19;10(1):5783. doi: 10.1038/s41467-019-13727-9.
4
Spatial heterogeneity of bacterial colonization across different gut segments following inter-species microbiota transplantation.不同种属微生物群移植后,肠道不同部位细菌定植的空间异质性。
Microbiome. 2020 Nov 18;8(1):161. doi: 10.1186/s40168-020-00917-7.
5
Encapsulation of beneficial probiotic bacteria in extracellular matrix from biofilm-forming Bacillus subtilis.将有益的益生菌细菌包埋在枯草芽孢杆菌生物膜形成的细胞外基质中。
Artif Cells Nanomed Biotechnol. 2018;46(sup2):974-982. doi: 10.1080/21691401.2018.1476373. Epub 2018 May 27.
6
Parasite-Probiotic Interactions in the Gut: sp. and Regulate Type-2 Inflammatory Responses and Modify the Gut Microbiota of Pigs During Helminth Infection.肠道中的寄生虫-益生菌相互作用:sp. 调节 2 型炎症反应,并在寄生虫感染期间改变猪的肠道微生物群。
Front Immunol. 2022 Jan 5;12:793260. doi: 10.3389/fimmu.2021.793260. eCollection 2021.
7
Physiologically Inspired Mucin Coated Nissle 1917 Enhances Biotherapy by Regulating the Pathological Microenvironment to Improve Intestinal Colonization.受生理启发的粘蛋白涂层益生菌 1917 通过调节病理性微环境增强生物治疗,以改善肠道定植。
ACS Nano. 2022 Mar 22;16(3):4041-4058. doi: 10.1021/acsnano.1c09681. Epub 2022 Mar 1.
8
Molecular analysis of autochthonous microbiota along the digestive tract of juvenile grouper Epinephelus coioides following probiotic Bacillus pumilus administration.短小芽孢杆菌益生菌给药后斜带石斑鱼幼鱼消化道内本土微生物群的分子分析
J Appl Microbiol. 2011 Apr;110(4):1093-103. doi: 10.1111/j.1365-2672.2011.04967.x. Epub 2011 Feb 23.
9
Molecular genetics for probiotic engineering: dissecting lactic acid bacteria.益生菌工程的分子遗传学:剖析乳酸菌。
Trends Microbiol. 2022 Mar;30(3):293-306. doi: 10.1016/j.tim.2021.07.007. Epub 2021 Aug 24.
10
Dietary Additive Probiotics Modulation of the Intestinal Microbiota.膳食添加剂益生菌对肠道微生物群的调节作用。
Protein Pept Lett. 2017;24(5):382-387. doi: 10.2174/0929866524666170223143615.

引用本文的文献

1
A multicellular self-organized probiotic platform for oral delivery enhances intestinal colonization.一种用于口服给药的多细胞自组织益生菌平台可增强肠道定植。
Nat Commun. 2025 Aug 1;16(1):7060. doi: 10.1038/s41467-025-62349-x.
2
Controlled Release of Microorganisms from Engineered Living Materials.工程化活材料中微生物的控释
ACS Appl Mater Interfaces. 2025 Jul 16;17(28):40326-40339. doi: 10.1021/acsami.5c11155. Epub 2025 Jul 8.
3
Modified probiotics and the related combinatorial therapeutics.改良益生菌及相关联合疗法。

本文引用的文献

1
Biointerfacial self-assembly generates lipid membrane coated bacteria for enhanced oral delivery and treatment.生物界面自组装生成脂质膜包裹的细菌,用于增强口服递送和治疗效果。
Nat Commun. 2019 Dec 19;10(1):5783. doi: 10.1038/s41467-019-13727-9.
2
Demystifying the manipulation of host immunity, metabolism, and extraintestinal tumors by the gut microbiome.揭开肠道微生物组对宿主免疫、代谢和肠外肿瘤的操纵之谜。
Signal Transduct Target Ther. 2019 Oct 12;4:41. doi: 10.1038/s41392-019-0074-5. eCollection 2019.
3
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice.
Acta Pharm Sin B. 2025 May;15(5):2431-2453. doi: 10.1016/j.apsb.2025.03.021. Epub 2025 Mar 14.
4
Decorating probiotics with a triggerable and catalytic shell for synergistically enhanced colitis biotherapy.用可触发且具有催化作用的外壳修饰益生菌以协同增强结肠炎生物疗法。
Mater Today Bio. 2025 May 12;32:101861. doi: 10.1016/j.mtbio.2025.101861. eCollection 2025 Jun.
5
Self-Adjusting Engineered Probiotic for Targeted Tumor Colonization and Local Therapeutics Delivery.用于靶向肿瘤定植和局部治疗递送的自调节工程益生菌
Adv Sci (Weinh). 2025 Aug;12(31):e06486. doi: 10.1002/advs.202406486. Epub 2025 May 28.
6
Surface engineering as a potential strategy to enhance desiccation tolerance of beneficial bacteria.表面工程作为提高有益细菌耐干燥性的潜在策略。
Front Microbiol. 2025 Apr 11;16:1576511. doi: 10.3389/fmicb.2025.1576511. eCollection 2025.
7
Preclinical Assessment of Living Therapeutic Materials: State-of-Art and Challenges.活性治疗材料的临床前评估:现状与挑战
ACS Biomater Sci Eng. 2025 May 12;11(5):2584-2600. doi: 10.1021/acsbiomaterials.5c00247. Epub 2025 Apr 15.
8
The Encapsulation Strategies for Targeted Delivery of Probiotics in Preventing and Treating Colorectal Cancer: A Review.益生菌靶向递送预防和治疗结直肠癌的封装策略:综述
Adv Sci (Weinh). 2025 May;12(18):e2500304. doi: 10.1002/advs.202500304. Epub 2025 Apr 7.
9
Isolation of derivatives from the food-grade probiotic CNCM I-4884 with enhanced anti- activity.从具有增强抗菌活性的食品级益生菌CNCM I-4884中分离衍生物。
Gut Microbes. 2025 Dec;17(1):2474149. doi: 10.1080/19490976.2025.2474149. Epub 2025 Mar 27.
10
Self-Nourishing and Armored Probiotics via Egg-Inspired Encapsulation.通过受鸡蛋启发的封装实现自我滋养和有保护外壳的益生菌
Adv Healthc Mater. 2025 Apr;14(11):e2405219. doi: 10.1002/adhm.202405219. Epub 2025 Mar 19.
国际共识会议关于粪便银行在临床实践中进行粪便微生物群移植。
Gut. 2019 Dec;68(12):2111-2121. doi: 10.1136/gutjnl-2019-319548. Epub 2019 Sep 28.
4
Camouflaging bacteria by wrapping with cell membranes.用细胞膜包裹细菌进行伪装。
Nat Commun. 2019 Aug 6;10(1):3452. doi: 10.1038/s41467-019-11390-8.
5
Healthspan and lifespan extension by fecal microbiota transplantation into progeroid mice.粪便微生物群移植延长早衰小鼠的健康寿命和寿命。
Nat Med. 2019 Aug;25(8):1234-1242. doi: 10.1038/s41591-019-0504-5. Epub 2019 Jul 22.
6
Surviving as a Community: Antibiotic Tolerance and Persistence in Bacterial Biofilms.作为一个社区的生存之道:细菌生物膜中的抗生素耐药性和持久性。
Cell Host Microbe. 2019 Jul 10;26(1):15-21. doi: 10.1016/j.chom.2019.06.002.
7
Microbiota therapy acts via a regulatory T cell MyD88/RORγt pathway to suppress food allergy.微生物组疗法通过调节性 T 细胞 MyD88/RORγt 途径抑制食物过敏。
Nat Med. 2019 Jul;25(7):1164-1174. doi: 10.1038/s41591-019-0461-z. Epub 2019 Jun 24.
8
Nanophotosensitizer-engineered Salmonella bacteria with hypoxia targeting and photothermal-assisted mutual bioaccumulation for solid tumor therapy.基于乏氧靶向和光热辅助互生物积累的纳米光增敏剂工程化沙门氏菌用于实体瘤治疗。
Biomaterials. 2019 Sep;214:119226. doi: 10.1016/j.biomaterials.2019.119226. Epub 2019 May 24.
9
Non-invasive delivery strategies for biologics.生物制剂的非侵入性递送策略。
Nat Rev Drug Discov. 2019 Jan;18(1):19-40. doi: 10.1038/nrd.2018.183. Epub 2018 Nov 30.
10
A platform of genetically engineered bacteria as vehicles for localized delivery of therapeutics: Toward applications for Crohn's disease.一种作为治疗药物局部递送载体的基因工程细菌平台:迈向克罗恩病的应用
Bioeng Transl Med. 2018 Sep 23;3(3):209-221. doi: 10.1002/btm2.10113. eCollection 2018 Sep.